Snehal Shah

Chief Tech/Sci/R&D Officer at OCULIS HOLDING AG

Health Technology

Consumer Services

Profile

Snehal Shah is currently the President-Research & Development at Oculis Holding AG.
Previously, Dr. Shah worked as a Member-Hisamitsu Group at Noven Pharmaceuticals, Inc. from 2012 to 2017.
Dr. Shah also held the position of SVP, Chief Regulatory & Product Strategy Officer at IVERIC bio, Inc. Dr. Shah holds a doctorate degree from the University of Kansas and an undergraduate degree from Rutgers University- Newark.

Snehal Shah active positions

Companies	Position	Start
OCULIS HOLDING AG	Chief Tech/Sci/R&D Officer	2024-04-09

All active positions of Snehal Shah

Former positions of Snehal Shah

Companies	Position	End
Noven Pharmaceuticals, Inc. Noven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Noven Pharmaceuticals, Inc. operates as a pharmaceutical company with transdermal expertise. It specializes in the research and development, manufacture, marketing, and sale of prescription pharmaceutical products. The company was founded in 1987 and is headquartered in Miami, FL.	Corporate Officer/Principal	2016-12-31
IVERIC BIO, INC.	General Counsel	-

See the detail of Snehal Shah's experience

Training of Snehal Shah

Rutgers University- Newark	Undergraduate Degree
University of Kansas	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Snehal Shah's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
OCULIS HOLDING AG	Health Technology

Private companies	2
IVERIC bio, Inc. IVERIC bio, Inc. Pharmaceuticals: GenericHealth Technology IVERIC bio, Inc. operates as a biopharmaceutical company. The firm engages in discovering, developing and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Its product candidates include Zimura and Gene Therapy. The company was founded by David R. Guyer and Samir Chandrakant Patel on January 5, 2007 and is headquartered in Parsippany, NJ.	Health Technology
Noven Pharmaceuticals, Inc. Noven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Noven Pharmaceuticals, Inc. operates as a pharmaceutical company with transdermal expertise. It specializes in the research and development, manufacture, marketing, and sale of prescription pharmaceutical products. The company was founded in 1987 and is headquartered in Miami, FL.	Health Technology